The Bill & Melinda Gates Foundation is making an unusual investment in a biotech start-up’s experimental cancer trial, hoping that its novel technology will one day allow HIV patients to rebuild their immune systems.
比尔及梅琳达•盖茨基金会(Bill & Melinda Gates Foundation)正在对一家生物技术初创公司的实验性癌症试验进行一项不同寻常的投资，希望其新技术有朝一日能让艾滋病患者重建他们的免疫系统。
您已阅读9%（368字），剩余91%（3873字）包含更多重要信息，订阅以继续探索完整内容，并享受更多专属服务。